HD 101

CME- HD 101

 

COURSE DESCRIPTION:

TO RECEIVE CME CREDITS FOR THESE ACTIVITIES, you must complete the HDSA registration, the self-assessment, view the recorded lecture and complete the post assessment and evaluation. Each successfully completed activity provides one credit.

 

PURPOSE STATEMENT:

These online CME activities are designed to offer expert knowledge about Huntington’s disease (HD) to primary care providers and family practitioners who care for people with HD at the local level. They also target neurologists and psychiatrists who are not familiar with HD. The activity will cover the natural history of the disease, genetics of HD, the psychiatric, neuropsychological and motor symptoms of the disease with treatment options as well as covering Juvenile Onset HD, assembling a team to provide care, information on research and clinical trials for people with HD and documenting disability for a person with HD.

 

TARGET AUDIENCE:

The target audience for this self-study CME activity is primary care providers, family practitioners, general neurologists and psychiatrists.

 

ACCREDITATION STATEMENT:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Alabama School of Medicine, the UAB Department of Neurology, and the Huntington’s Disease Society of America (HDSA). The University of Alabama School of Medicine is accredited by the ACCME to provide continuing medical education to all physicians. 

 

CREDIT DESIGNATION: The University of Alabama School of Medicine designates each activity for a maximum of 1 AMA PRA Category 1 Credit. Each physician/learner should claim only those credits that he/she actually spent in the activity.

 

OFF LABEL DISCLOSURE:

These educational activities include discussion of the off-label use of some medications.

 

TECHNICAL REQUIREMENTS:

The following hardware/software specifications must be met or exceeded to complete these activities:

  • Web browser and Internet connection
  • Free flash plug-in version 8 or higher
  • Computer equipped with audio output (speakers or headphones)
  • Printer
  • Pop-up windows enabled for viewing support materials

 

INSTRUCTIONS TO PARTICIPANTS:

  1. There is no fee charged for participation in this CME activity.
  2. Read the target audience, purpose statement, and author disclosures on this screen.
  3. Study the educational activity as presented on this web site.
  4. Read, complete and submit answers to the Review Questions and complete the Evaluation Form. These documents are available on the last screen of this CME activity.
  5. Print the CME certificate.

 

ADDITIONAL RESOURCES:

For Huntington’s disease: Huntington’s Disease Society of America (HDSA): www.hdsa.org

For Clinical Trials: www.hdsa.org; www.clinicaltrials.gov  

 

FACULTY INFORMATION AND DISCLOSURE:

The University of Alabama School of Medicine requires that faculty participating in CME activity disclose any relationship that might pose a potential, apparent, or real conflict of interest. The authors of this CME activity indicated that there were the following relationships to disclose.

 

Kevin Biglan, MD: Research support from the NINDS, MJFF, Lundbeck Inc., NeuroSearch, Google, Excellus/BC; consulting fees from Lundbeck, Inc.

Thomas Bird, MD: Licensing fees and Speaker’s bureau for Athena Diagnostics

Samuel Frank, MD: Research and consulting fees from Lundbeck, Inc.

Martha Nance, MD: Research support grant from Medivation and NeuroSearch; Spouse on Speaker’s Bureau for Roche and Genentech.

Jane Paulsen, PhD: Dr. Paulsen has no relationships with proprietary entities producing health care goods or services related to the presented content.

Adam Rosenblatt, MD: Consulting fees from Lundbeck, Inc. Disclosures will appear on presentation

Vicki Wheelock, MD: Honorarium for A Physician’s Guide to the Management of Huntington’s Disease (Third Edition), educational grant from Lundbeck, Inc.

 

DISCLAIMER:

These materials may discuss therapeutic products that have not been approved by the U.S. Food and Drug Administration and off-label uses of approved products. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 

LEARNING OBJECTIVES: After completing this self-directed study, the participant should be able to:

  • Understand the diagnostic criteria and current neurologic management of Huntington’s disease (ABMS/ACGME Competencies: Medical Knowledge, Patient Care).
  • Understand the psychiatric manifestations of HD and their treatment (ABMS/ACGME Competencies: Medical Knowledge, Patient Care).
  • Gain awareness of cognitive features of HD and the role of neuropsychological assessment (ABMS/ACGME Competencies: Medical Knowledge, Patient Care).
  • Understand the benefits, limitations and ethical issues of genetic testing in HD (ABMS/ACGME Competencies: Medical Knowledge, Patient Care).
  • Appreciate the role of the multidisciplinary team in the management of HD including long-term care (ABMS/ACGME Competencies: Medical Knowledge, Patient Care).
  • Acquire knowledge and understanding of prevalence and diagnostic procedures utilized for the juvenile form of HD (ABMS/ACGME Competencies: Medical Knowledge, Patient Care).
  • Expand understanding of unique issues pertaining to quality of life in HD (ABMS/ACGME Competency: Patient Care).
  • Increase knowledge of resources to connect HD patients and families with clinical research opportunities in their geographic areas (ABMS/ACGME Competency: Patient Care).

 

Module

Topic

Presenter

Registration LInk

1

Natural History and Introduction to the series

Sam Frank, MD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13335&TestType=Pretest

2

Genetic Factors in Huntington’s Disease

Thomas Bird, M.D.

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13336&TestType=Pretest

3

The Prodrome of Huntington’s Disease

Jane Paulsen, PhD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13337&TestType=Pretest

 

4

Cognitive Features of HD

Jane Paulsen, PhD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13338&TestType=Pretest

 

5

Psychiatric Syndromes in Huntington’s Disease

Adam Rosenblatt, MD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13339&TestType=Pretest

6

Motor Dysfunction and Neurological Care

Vicki Wheelock, MD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13340&TestType=Pretest

7

Juvenile Onset HD

Martha Nance, MD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13341&TestType=Pretest

 

8

Team-based Care for HD- From Beginning to End

Martha Nance, MD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13342&TestType=Pretest

9

An Overview of Experimental Therapeutics in Huntington’s Disease

Kevin Bigland, MD, MPH

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13343&TestType=Pretest

10

Disability, Advocacy and Final Thoughts

Sam Frank, MD

http://www.assessments.cme.uab.edu/Default.aspx?CourseCode=EM-13344&TestType=Pretest